(Q37816561)

23 August 2017

1 reference

title

Chemokines in cancer related inflammation (English)

1 reference

23 August 2017

0 references

4

1 reference

23 August 2017

3

0 references

author name string

Paola Allavena

series ordinal

1

1 reference

23 August 2017

Giovanni Germano

series ordinal

2

1 reference

23 August 2017

language of work or name

English

0 references

publication date

4 December 2010

1 reference

Experimental Cell Research

23 August 2017

published in

1 reference

23 August 2017

volume

317

1 reference

23 August 2017

issue

5

1 reference

23 August 2017

page(s)

664-673

1 reference

Inflammatory chemokines in cancer growth and progression

23 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.013

Chemokines and chemokine receptors: new insights into cancer-related inflammation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.013

Cancer-related inflammation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.013

The chemokine system in cancer biology and therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.013

Nuclear factor-kappaB in cancer development and progression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.013

Immune cells as mediators of solid tumor metastasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.013

Regulation of the macrophage content of neoplasms by chemoattractants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.013

Properties of monocyte chemotactic and activating factor (MCAF) purified from a human fibrosarcoma cell line

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.013

Ras-induced interleukin-8 expression plays a critical role in tumor growth and angiogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.013

The BRAF-MAPK signaling pathway is essential for cancer-immune evasion in human melanoma cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.013

Induction of a proinflammatory program in normal human thyrocytes by the RET/PTC1 oncogene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.013

Antitumor and anti-inflammatory effects of trabectedin on human myxoid liposarcoma cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.013

Mast cells are required for angiogenesis and macroscopic expansion of Myc-induced pancreatic islet tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.013

Identification of GRO1 as a critical determinant for mutant p53 gain of function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.013

CCR7 signalling as an essential regulator of CNS infiltration in T-cell leukaemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.013

The human herpesvirus 8 chemokine receptor vGPCR triggers autonomous proliferation of endothelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.013

The cytomegalovirus-encoded chemokine receptor US28 promotes intestinal neoplasia in transgenic mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.013

Regulation of the chemokine receptor CXCR4 by hypoxia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.013

Abrogation of TGF-beta signaling enhances chemokine production and correlates with prognosis in human breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.013

Nf-kappa B, chemokine gene transcription and tumour growth

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.013

NF-κB inducing kinase: A key regulator in the immune system and in cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.013

Homing and invasiveness of MLL/ENL leukemic cells is regulated by MEF2C.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.013

Transactivation of CXCR4 by the insulin-like growth factor-1 receptor (IGF-1R) in human MDA-MB-231 breast cancer epithelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.013

A role for chemokine receptor transactivation in growth factor signaling.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.013

The inflammatory cytokine tumor necrosis factor-alpha regulates chemokine receptor expression on ovarian cancer cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.013

The lymphatic system controls intestinal inflammation and inflammation-associated colon cancer through the chemokine decoy receptor D6

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.013

The chemokine system: redundancy for robust outputs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.013

CCL2 (monocyte chemoattractant protein-1) and cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.013

Chemokine-mediated rapid turnover of myeloid-derived suppressor cells in tumor-bearing mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.013

Cancer and the chemokine network

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.013

The inflammatory chemokines CCL2 and CCL5 in breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.013

Tumour-educated macrophages promote tumour progression and metastasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.013

Tumor-associated macrophages (TAM) as major players of the cancer-related inflammation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.013

Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.013

The role of tumour-associated macrophages in tumour progression: implications for new anticancer therapies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.013

Macrophages: Obligate Partners for Tumor Cell Migration, Invasion, and Metastasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.013

Identification of Biologically Active Chemokine Isoforms from Ascitic Fluid and Elevated Levels of CCL18/Pulmonary and Activation-regulated Chemokine in Ovarian Carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.013

Tumor immune escape by the loss of homeostatic chemokine expression.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.013

Altered macrophage differentiation and immune dysfunction in tumor development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.013

Myeloid-derived suppressor cells as regulators of the immune system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.013

Manipulating the chemokine-chemokine receptor network to treat cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.013

RANTES secretion by gene-modified tumor cells results in loss of tumorigenicity in vivo: role of immune cell subpopulations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.013

Type, density, and location of immune cells within human colorectal tumors predict clinical outcome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.013

CD3+ cells at the invasive margin of deeply invading (pT3–T4) colorectal cancer and risk of post-surgical metastasis: a longitudinal study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.013

CXCR3/CXCR3 ligand biological axis impairs RENCA tumor growth by a mechanism of immunoangiostasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.013

Abundant expression of CXCL9 (MIG) by stromal cells that include dendritic cells and accumulation of CXCR3+ T cells in lymphocyte-rich gastric carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.013

Selective infiltration of CCR5(+)CXCR3(+) T lymphocytes in human colorectal carcinoma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.013

NK cells that are activated by CXCL10 can kill dormant tumor cells that resist CTL-mediated lysis and can express B7-H1 that stimulates T cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.013

Natural killer cell accumulation in tumors is dependent on IFN-gamma and CXCR3 ligands

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.013

Enhanced expression and shedding of the transmembrane chemokine CXCL16 by reactive astrocytes and glioma cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.013

The chemokine receptor CXCR6 and its ligand CXCL16 are expressed in carcinomas and inhibit proliferation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.013

Radiation-induced CXCL16 release by breast cancer cells attracts effector T cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.013

Tumoural CXCL16 expression is a novel prognostic marker of longer survival times in renal cell cancer patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.013

High-level expression of chemokine CXCL16 by tumor cells correlates with a good prognosis and increased tumor-infiltrating lymphocytes in colorectal cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.013

The chemokine CXCL16 and its receptor, CXCR6, as markers and promoters of inflammation-associated cancers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.013

Priming of naive T cells inside tumors leads to eradication of established tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.013

Secondary lymphoid tissue chemokine mediates T cell-dependent antitumor responses in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.013

Characterization of the CCL21-mediated melanoma-specific immune responses and in situ melanoma eradication

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.013

Regulated expression of CCL21 in the prostate tumor microenvironment inhibits tumor growth and metastasis in an orthotopic model of prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.013

Cancer CXC chemokine networks and tumour angiogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.013

Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.013

VEGF-A stimulates lymphangiogenesis and hemangiogenesis in inflammatory neovascularization via macrophage recruitment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.013

Cell cycle-dependent expression of CXC chemokine receptor 3 by endothelial cells mediates angiostatic activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.013

CXC chemokines: angiogenesis, immunoangiostasis, and metastases in lung cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.013

Angiostatic immune reaction in colorectal carcinoma: Impact on survival and perspectives for antiangiogenic therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.013

Expression of IP-10 related to angiogenesis in uterine cervical cancers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.013

An amino-bisphosphonate targets MMP-9-expressing macrophages and angiogenesis to impair cervical carcinogenesis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.013

Infiltrating neutrophils mediate the initial angiogenic switch in a mouse model of multistage carcinogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.013

CXCR4: a key receptor in the crosstalk between tumor cells and their microenvironment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.013

Role of high expression levels of CXCR4 in tumor growth, vascularization, and metastasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.013

Chemokine receptor CCR6 expression level and liver metastases in colorectal cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.013

The chemokine receptor CX3CR1 is involved in the neural tropism and malignant behavior of pancreatic ductal adenocarcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.013

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.013

CXCR1 and CXCR2 enhances human melanoma tumourigenesis, growth and invasion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.013

Autocrine and paracrine chemokine receptor 7 activation in head and neck cancer: implications for therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.013

Immune Evasion by Murine Melanoma Mediated through CC Chemokine Receptor-10

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.013

An antagonist of the chemokine receptor CXCR4 induces mitotic catastrophe in ovarian cancer cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.013

Positive feedback activation of estrogen receptors by the CXCL12-CXCR4 pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.013

Transactivation of the epidermal growth factor receptor by formylpeptide receptor exacerbates the malignant behavior of human glioblastoma cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.013

Oncogene-induced cell senescence--halting on the road to cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.013

Living on a break: cellular senescence as a DNA-damage response

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.013

Senescence-associated secretory phenotypes reveal cell-nonautonomous functions of oncogenic RAS and the p53 tumor suppressor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.013

Chemokine signaling via the CXCR2 receptor reinforces senescence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.013

Cell surface-bound IL-1alpha is an upstream regulator of the senescence-associated IL-6/IL-8 cytokine network

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.013

Oncogene-induced senescence relayed by an interleukin-dependent inflammatory network

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.013

Involvement of chemokine receptors in breast cancer metastasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.013

CXCR4 mediates the proliferation of glioblastoma progenitor cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.013

Expression of CXC chemokine receptors 1-5 and their ligands in human glioma tissues: role of CXCR4 and SDF1 in glioma cell proliferation and migration.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.013

CXCR4 is a major chemokine receptor on glioma cells and mediates their survival.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.013

Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.013

Human glioblastoma tumours and neural cancer stem cells express the chemokine CX3CL1 and its receptor CX3CR1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.013

Distinct expression of CXCL8 and its receptors CXCR1 and CXCR2 and their association with vessel density and aggressiveness in malignant melanoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.013

CXCR3 expression is associated with poor survival in breast cancer and promotes metastasis in a murine model.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.013

The CXCR5 chemokine receptor is expressed by carcinoma cells and promotes growth of colon carcinoma in the liver

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.013

CX3CR1-fractalkine expression regulates cellular mechanisms involved in adhesion, migration, and survival of human prostate cancer cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.013

Prediction of lymph node metastasis in colorectal carcinoma by expressionof chemokine receptor CCR7

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.013

Overexpression of CCR7 mRNA in nonsmall cell lung cancer: correlation with lymph node metastasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.013

CCL21 chemokine regulates chemokine receptor CCR7 bearing malignant melanoma cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.013

Expression of CC chemokine receptor-7 and regional lymph node metastasis of B16 murine melanoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.013

Chemokine receptor CCR6 expression level and aggressiveness of prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.013

The chemokine CCL20 and its receptor CCR6 in human malignancy with focus on colorectal cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.013

Survey of chemokine receptor expression reveals frequent co-expression of skin-homing CCR4 and CCR10 in adult T-cell leukemia/lymphoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.013

Functional expression of the eotaxin receptor CCR3 in CD30+ cutaneous T-cell lymphoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.013

Functional CCR9 expression is associated with small intestinal metastasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.013

Potential role of CCL27 and CCR10 expression in melanoma progression and immune escape

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.013

CC chemokines and the receptors CCR3 and CCR5 are differentially expressed in the nonneoplastic leukocytic infiltrates of Hodgkin disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.013

Nonapical and cytoplasmic expression of interleukin-8, CXCR1, and CXCR2 correlates with cell proliferation and microvessel density in prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.013

Mesenchymal stem cells within tumour stroma promote breast cancer metastasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.013

7 January 2021

Fibroblasts in cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.013

Chemokines at the crossroads of tumor-fibroblast interactions that promote malignancy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.013

Involvement of CXCL12 and CXCR4 in Lymph Node Metastases and Development of Oral Squamous Cell Carcinomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.013

Tumour necrosis factor and cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.013

CCL2 as an important mediator of prostate cancer growth in vivo through the regulation of macrophage infiltration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.013

A single treatment with microcapsules containing a CXCR4 antagonist suppresses pulmonary metastasis of murine melanoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.013

T140 analogs as CXCR4 antagonists identified as anti-metastatic agents in the treatment of breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.013

Inhibition of the CXCR4/CXCL12 chemokine pathway reduces the development of murine pulmonary metastases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.013

Effects of CXCR4 antagonist CTCE-9908 on prostate tumor growth

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.013

Mobilization of hematopoietic progenitor cells in healthy volunteers by AMD3100, a CXCR4 antagonist

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.013

The AMD3100 story: the path to the discovery of a stem cell mobilizer (Mozobil).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.013

Fully humanized neutralizing antibodies to interleukin-8 (ABX-IL8) inhibit angiogenesis, tumor growth, and metastasis of human melanoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.013

Anti-inflammatory properties of the novel antitumor agent yondelis (trabectedin): inhibition of macrophage differentiation and cytokine production

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.013

10.1016/J.YEXCR.2010.11.013

7 January 2021

Identifiers

DOI

1 reference

23 August 2017

1 reference